| scholarly article | Q13442814 |
| P356 | DOI | 10.1126/SCIENCE.290.5500.2315 |
| P698 | PubMed publication ID | 11125148 |
| P50 | author | James V. Haxby | Q23992770 |
| Pietro Pietrini | Q25308513 | ||
| P2093 | author name string | Furey ML | |
| P433 | issue | 5500 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2315-2319 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Cholinergic enhancement and increased selectivity of perceptual processing during working memory | |
| P478 | volume | 290 |
| Q35014026 | 'Smart drugs': do they work? Are they ethical? Will they be legal? |
| Q44558638 | (-)-9-Dehydrogalanthaminium bromide, a new cholinesterase inhibitor, enhances place and object recognition memory in young and old rats. |
| Q51910308 | A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia. |
| Q46201288 | A cross-species investigation of acetylcholine, attention, and feature binding |
| Q46794182 | A double-blind, placebo-controlled trial of donepezil for the treatment of menopause-related cognitive loss |
| Q36610058 | APOE E4 Carriers show prospective memory enhancement under nicotine, and evidence for specialisation within medial BA10. |
| Q90252559 | Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task |
| Q45917876 | Acute cognitive effects of donepezil in young, healthy volunteers. |
| Q46391646 | Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial |
| Q42137909 | Adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: a placebo-controlled pilot study |
| Q33933877 | Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study |
| Q42187811 | Alpha rhythm oscillations and MMSE scores are differently modified by transdermal or oral rivastigmine in patients with Alzheimer's disease. |
| Q35560078 | Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease |
| Q44202993 | An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia |
| Q26822244 | Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review |
| Q34502083 | Assessing the prospect of donepezil in improving cognitive impairment in patients with schizophrenia |
| Q51901913 | Associations between AQT processing speed and neuropsychological tests in neuropsychiatric patients. |
| Q44556977 | Auditory selective attention in young and elderly adults: the selection of single versus conjoint features |
| Q31002137 | Basal Forebrain Atrophy Contributes to Allocentric Navigation Impairment in Alzheimer's Disease Patients |
| Q37396195 | Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology. |
| Q26998400 | Boosting visual cortex function and plasticity with acetylcholine to enhance visual perception |
| Q33837663 | Both a nicotinic single nucleotide polymorphism (SNP) and a noradrenergic SNP modulate working memory performance when attention is manipulated |
| Q50687939 | Brain Network Activation (BNA) reveals scopolamine-induced impairment of visual working memory. |
| Q36848923 | Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression |
| Q51606155 | Changes in extrafrontal integrity and cognition in frontal lobe epilepsy: a diffusion tensor imaging study. |
| Q35990281 | Choline transporters, cholinergic transmission and cognition |
| Q34192201 | Cholinergic Enhancement Augments Magnitude and Specificity of Visual Perceptual Learning in Healthy Humans |
| Q37712599 | Cholinergic Potentiation Improves Perceptual-Cognitive Training of Healthy Young Adults in Three Dimensional Multiple Object Tracking |
| Q44095984 | Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis |
| Q46275722 | Cholinergic augmentation modulates visual task performance in sleep-deprived young adults |
| Q48831751 | Cholinergic blockade under working memory demands encountered by increased rehearsal strategies: evidence from fMRI in healthy subjects. |
| Q37217895 | Cholinergic components of frontal lobe function and dysfunction |
| Q42451702 | Cholinergic deafferentation of the neocortex using 192 IgG-saporin impairs feature binding in rats. |
| Q49117336 | Cholinergic enhancement differentially modulates neural response to encoding during face identity and face location working memory tasks |
| Q34209512 | Cholinergic enhancement eliminates modulation of neural activity by task difficulty in the prefrontal cortex during working memory |
| Q44607398 | Cholinergic enhancement modulates neural correlates of selective attention and emotional processing |
| Q34434221 | Cholinergic enhancement of episodic memory in healthy young adults. |
| Q42218024 | Cholinergic enhancement of visual attention and neural oscillations in the human brain |
| Q36243867 | Cholinergic enhancement reduces functional connectivity and BOLD variability in visual extrastriate cortex during selective attention |
| Q36241033 | Cholinergic enhancement reduces orientation-specific surround suppression but not visual crowding. |
| Q37093002 | Cholinergic enhancement reduces spatial spread of visual responses in human early visual cortex |
| Q41898007 | Cholinergic modulation of a specific memory function of prefrontal cortex |
| Q36057102 | Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging |
| Q30881391 | Cholinergic modulation of learning and memory in the human brain as detected with functional neuroimaging |
| Q35689746 | Cholinergic modulation of visual working memory during aging: a parametric PET study |
| Q35543969 | Cholinergic modulation of working memory activity in primate prefrontal cortex |
| Q42453264 | Cholinergic optimization of cue-evoked parietal activity during challenged attentional performance |
| Q45954188 | Cholinergic stimulation enhances neural activity associated with encoding but reduces neural activity associated with retrieval in humans. |
| Q37019704 | Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health |
| Q37819134 | Cognitive enhancement by drugs in health and disease |
| Q44199597 | Cognitive mechanisms of nicotine on visual attention |
| Q46726459 | Cognitive performance of healthy young rats following chronic donepezil administration |
| Q33937187 | Comparison of the effects of transdermal and oral rivastigmine on cognitive function and EEG markers in patients with Alzheimer's disease |
| Q80728588 | Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes |
| Q46312849 | Donepezil enhances understanding of degraded speech in Alzheimer's disease |
| Q37279144 | Donepezil improves episodic memory in young individuals vulnerable to the effects of sleep deprivation. |
| Q46955607 | Donepezil treatment of topiramate-related cognitive dysfunction |
| Q45020579 | Donepezil-induced improvement in delayed matching accuracy by young and old rhesus monkeys |
| Q43175969 | Effects of acute psychosocial stress on working memory related brain activity in men. |
| Q44370320 | Effects of attention and emotion on repetition priming and their modulation by cholinergic enhancement |
| Q42528576 | Effects of cholinergic enhancement on conditioning-related responses in human auditory cortex. |
| Q44815999 | Effects of cholinergic enhancement on visual stimulation, spatial attention, and spatial working memory. |
| Q48134905 | Effects of cholinesterase inhibitor on brain activation in Alzheimer's patients measured with functional near-infrared spectroscopy. |
| Q36755406 | Effects of sleep deprivation on neural functioning: an integrative review. |
| Q43892728 | Endotoxin-induced changes in human working and declarative memory associate with cleavage of plasma "readthrough" acetylcholinesterase. |
| Q35830687 | Estradiol treatment altered anticholinergic-related brain activation during working memory in postmenopausal women |
| Q33779694 | Estrogen therapy and cognition: a review of the cholinergic hypothesis |
| Q26799402 | Estrogen-cholinergic interactions: Implications for cognitive aging |
| Q37945156 | Evaluation of state and trait biomarkers in healthy volunteers for the development of novel drug treatments in schizophrenia. |
| Q38299487 | Examining brain-cognition effects of ginkgo biloba extract: brain activation in the left temporal and left prefrontal cortex in an object working memory task |
| Q51031655 | Failing to ignore: paradoxical neural effects of perceptual load on early attentional selection in normal aging. |
| Q33898082 | Functional MRI detection of pharmacologically induced memory impairment |
| Q35803532 | Functional neuroimaging and behavioral correlates of capacity decline in visual short-term memory after sleep deprivation. |
| Q33195555 | Functional studies of cholinergic activity in normal and Alzheimer disease states by imaging technique. |
| Q48233971 | Gender-specific effects of prenatal and adolescent exposure to tobacco smoke on auditory and visual attention |
| Q28244159 | Glyconutrients and perception, cognition, and memory |
| Q30473426 | Human models as tools in the development of psychotropic drugs |
| Q43836496 | Imaging stroke recovery: lessons from Prozac |
| Q34293937 | Integrated brain activity in medial temporal and prefrontal areas predicts subsequent memory performance: human declarative memory formation at the system level |
| Q48434396 | Lapsing during sleep deprivation is associated with distributed changes in brain activation. |
| Q24598925 | Leveraging the cortical cholinergic system to enhance attention |
| Q37414015 | Mechanisms governing the reactivation-dependent destabilization of memories and their role in extinction |
| Q34355481 | Modes and models of forebrain cholinergic neuromodulation of cognition. |
| Q52014387 | Motor inhibition and learning impairments in school-aged children following exposure to organophosphate pesticides in infancy. |
| Q34321836 | Neurobiology of intelligence: science and ethics |
| Q30481358 | Neuroimaging of children following prenatal drug exposure |
| Q40515075 | Neuropsychological test performance in healthy volunteers before and after donepezil administration |
| Q33784782 | Nicotinic receptor gene CHRNA4 interacts with processing load in attention |
| Q35043600 | Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women |
| Q45238691 | Noradrenergic blockade and numeric working memory in humans |
| Q43972725 | Nuclear calcium signaling evoked by cholinergic stimulation in hippocampal CA1 pyramidal neurons. |
| Q48421813 | Paradoxical facilitation of object recognition memory after infusion of scopolamine into perirhinal cortex: implications for cholinergic system function. |
| Q35826190 | Pharmacological Mechanisms of Cortical Enhancement Induced by the Repetitive Pairing of Visual/Cholinergic Stimulation |
| Q37688304 | Pharmacological dissociation of novelty responses in the human brain |
| Q35810082 | Pharmacological manipulation of human working memory |
| Q43715955 | Pharmacological modulation of behavioral and neuronal correlates of repetition priming. |
| Q46437574 | Plasma level-dependent effects of methylphenidate on task-related functional magnetic resonance imaging signal changes. |
| Q40043095 | Positive effects of nicotine on cognition: the deployment of attention for prospective memory. |
| Q37029596 | Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder |
| Q33905343 | Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia |
| Q37338768 | Practice and difficulty evoke anatomically and pharmacologically dissociable brain activation dynamics |
| Q42321437 | Pro-cognitive drug effects modulate functional brain network organization |
| Q38219076 | Précis on The Cognitive-Emotional Brain |
| Q36886717 | Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia |
| Q37259258 | Recent advances in treating cognitive impairment in schizophrenia |
| Q50538637 | Regulation of Cognitive Processing by Hippocampal Cholinergic Tone. |
| Q37035894 | Regulation of the NMDA receptor-mediated synaptic response by acetylcholinesterase inhibitors and its impairment in an animal model of Alzheimer's disease |
| Q39040746 | Rejuvenating procholinergic treatments for cognition enhancement in AD: current challenges and future prospects |
| Q48116557 | Resting EEG sources correlate with attentional span in mild cognitive impairment and Alzheimer's disease |
| Q47139707 | Scopolamine Reduces Electrophysiological Indices of Distractor Suppression: Evidence from a Contingent Capture Task |
| Q36013263 | Scopolamine infused into perirhinal cortex improves object recognition memory by blocking the acquisition of interfering object information |
| Q46738259 | Scopolamine reduces persistent activity related to long-term encoding in the parahippocampal gyrus during delayed matching in humans. |
| Q35648191 | Selective effects of cholinergic modulation on task performance during selective attention |
| Q24812118 | Single subject pharmacological-MRI (phMRI) study: modulation of brain activity of psoriatic arthritis pain by cyclooxygenase-2 inhibitor |
| Q28166505 | Stroke, dementia, and drug delivery |
| Q30689629 | Technical aspects and utility of fMRI using BOLD and ASL. |
| Q35042798 | The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation |
| Q49077948 | The dysexecutive syndromes |
| Q41578180 | The expression of established cognitive brain states stabilizes with working memory development. |
| Q31132139 | The hemo-neural hypothesis: on the role of blood flow in information processing. |
| Q52002157 | The human basal forebrain integrates the old and the new. |
| Q44393705 | The modulatory effects of dopamine D1 and D2 receptor function on object working memory in humans |
| Q34161646 | The prefrontal cortex in sleep |
| Q35689769 | The prominent role of stimulus processing: cholinergic function and dysfunction in cognition |
| Q34700186 | The role of acetylcholine in cocaine addiction. |
| Q35236387 | Therapeutic approaches to age-associated neurocognitive disorders |
| Q42435326 | Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons |
| Q34706665 | Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview |
| Q40810950 | Time related effects on functional brain connectivity after serotonergic and cholinergic neuromodulation. |
| Q37056584 | Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option? |
| Q44696082 | Using fMRI to quantify the time dependence of remifentanil analgesia in the human brain |
| Q60040963 | Visual attention-related processing in Alzheimer's disease |
| Q46845142 | Visuospatial memory deficits emerging during nicotine withdrawal in adolescents with prenatal exposure to active maternal smoking |
| Q37550368 | When is diminishment a form of enhancement? Rethinking the enhancement debate in biomedical ethics |
Search more.